| Table 11 |
| Patient Survival by Age at First Transplant and by Time
since Transplant |
| For Patients Receiving their First Transplant of this type
between 07/01/1996 and 06/30/2000 |
| Center: University of Alabama Hospital, Birmingham, AL |
| Organ: LI: Liver
(Single-Organ Transplants Only) |
| |
|
|
|
|
|
|
|
|
|
|
Patient Survival by Time since First Transplant |
|
|
This Center |
|
United States |
|
|
1 Month |
1 Year |
3 Years |
|
1 Month |
1 Year |
3 Years |
| Adult (Age 18+) |
|
|
|
|
|
|
|
|
Transplants (n) 1 |
168 |
168 |
161 |
|
7,409 |
7,409 |
6,378 |
|
Patient Survival (%) 2 |
99.40 |
90.45 |
90.76 |
|
94.75 |
86.50 |
81.41 |
|
Expected Patient Survival (%) 3 |
95.49 |
87.21 |
82.20 |
|
NA |
NA |
NA |
|
P-value (2-sided) 4 |
0.008 |
0.198 |
0.005 |
|
NA |
NA |
NA |
|
Statistically different from expected |
Higher |
Not Different |
Higher |
|
NA |
NA |
NA |
|
Follow-up days reported (%) 5 |
98.0 |
91.4 |
89.7 |
|
91.4 |
83.7 |
82.6 |
|
Maximum Days of Follow-up (n) |
30 |
365 |
1,096 |
|
30 |
365 |
1,096 |
|
Follow-up forms filed (%) 6 |
100.0 |
97.6 |
96.9 |
|
99.8 |
99.3 |
97.5 |
|
|
|
|
|
|
|
|
|
| Pediatric (Age
< 18) |
|
|
|
|
|
|
|
|
Transplants (n) 1 |
16 |
16 |
22 |
|
857 |
857 |
870 |
|
Patient Survival (%) 2 |
80.36 |
73.05 |
84.78 |
|
93.24 |
87.24 |
84.60 |
|
Expected Patient Survival (%) 3 |
93.61 |
89.75 |
88.70 |
|
NA |
NA |
NA |
|
P-value (2-sided) 4 |
0.157 |
0.154 |
0.835 |
|
NA |
NA |
NA |
|
Statistically different from expected |
Not Different |
Not Different |
Not Different |
|
NA |
NA |
NA |
|
Follow-up days reported (%) 5 |
92.7 |
84.3 |
87.9 |
|
88.2 |
77.4 |
75.0 |
|
Maximum Days of Follow-up (n) |
30 |
365 |
1,096 |
|
30 |
365 |
1,096 |
|
Follow-up forms filed (%) 6 |
100.0 |
93.8 |
100.0 |
|
99.6 |
99.4 |
97.5 |
| |
|
|
|
|
|
|
|
|
| Transplant Time Period |
7/1/98-6/30/00 |
7/1/98-6/30/00 |
7/1/96-6/30/98 |
|
7/1/98-6/30/00 |
7/1/98-6/30/00 |
7/1/96-6/30/98 |
| 1 Transplants during
the time period indicated in the last row of the table. |
| 2 Because different
cohorts are followed for each time period, it is possible for reported 3-year
survival to exceed 1-year survival. |
| 3 Based on U.S.
patient mortality rates adjusted for recipient and donor characteristics as indicated in the Analytical Methods. |
| 4 A
p-value less than or equal to 0.05 indicates that the difference between the
actual and expected patient survival is probably real and is not due to
random chance, while a p-value greater than 0.05 indicates that the
difference could possibly be due to random chance. |
| 5 Of
days expected to be included in the follow-up period, the percentage of days
covered by follow-up reporting for these tranplants. A low percent may indicate a
non-representative sample from this facility for followup. This measures the possibility that events
such as failure have occurred without being reported, and it is not a measure
of compliance. |
| 6
Percent of 3 month follow-up forms filed is used for 1 month survival;
percent of 1 year follow-up forms filed is used for 1 year survival; and
percent of 3 year follow-up forms filed is used for 3 year survival. |
| Based on data available as of 11/01/2001. |
|
|
|
|
|
|
|
|
|
